Extracellular Vesicles 2026 Shenzhen Conference is held in Shenzhen, China -the hub of technology development and referred to as the Silicon Valley of China.
The critical mass of researchers and companies in Shenzhen provides the driver for this conference to focus on the key topics and areas in Extracellular Vesicles (EVs) research as they expand and evolve in 2026.
Emphasis at this event is placed on the technologies that are being developed driving EV Research. Also the biomarker (diagnostic) potential and therapeutics development using EVs are explored at this conference.
This conference is held co-located and concurrently with the Microfluidics in Biomedical Innovation 2026 Shenzhen Conference enabling scientific networking and business development.
The commercial program at this conference complements the scientific program, and the host welcomes companies to engage at this conference as exhibitors and technology spotlight speakers - this ecosystem enables scientific advancement and commercial development.
Agenda
-
Current Areas of Research in the Exosomes and Extracellular Vesicles (EVs) Field
-
Areas of Focus in LNP Technology Development
-
Exosome/EV Diagnostics Development
-
Exosome/EV Therapeutics Development
-
Instrumentation and Reagents for Exosome/EV Research/LNP Research
-
Emerging and Disruptive Technologies in the EV Research Field
Speakers
- Andreas Möller, Professor, Director, JC STEM Lab of Personalized Cancer Medicine, Prince of Wales Hospital, Chinese University of Hong Kong; Executive Chair ISEV
- Gang Long, Professor, Fudan University
- Hsueh-Chia Chang, Bayer Professor of Chemical and Biomolecular Engineering, University of Notre Dame; Co-Founder & CTO, Aopia Biosciences -- Conference Senior Chairperson
- Leslie Yeo, Distinguished Professor, Royal Melbourne Institute of Technology (RMIT); Chief Editor, Biomicrofluidics
- Qinglu Zeng, Professor, The Hong Kong University of Science and Technology
- Yiyao Huang, Research Scientist, Nanfang Hospital, Southern Medical University; Member-at-Large, ISEV; Secretary, CSEV - Conference Co-Chair
- Chi-Ying Huang, Distinguished Professor and Dean, Sciences in Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taiwan, ROC
- Haifang Yin, Professor, Head of Medical Technology Division, Tianjin Medical University
- Judy Yam, Professor, The University of Hong Kong; Associate Editor JEV
- Levent Yobas, Professor, Department of Electronic and Computer Engineering, Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology
- Sai Kiang Lim, Research Director, Paracrine Therapeutics; Associate Research Professor (Adj), Surgery, YLL School of Medicine, National University of Singapore
- Zhigang Li, Associate Professor, Seventh Affiliated Hospital, Sun Yat-sen University
- Dominique PV de Kleijn, Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht
- Hsiu-Jung Liao, Researcher, Department of Medical Research, Far Eastern Memorial Hospital, Assistant Professor, Institute of Biopharmaceutical Science, National Yang-Ming University, Taiwan, ROC
- Lei Zheng, Professor of Medicine, Vice President, Nanfang Hospital Southern Medical University; Vice President, Chinese Society for Extracellular Vesicles
- Linli Lv, Professor, Institute of Nephrology, Southeast University
- Xiaomei Yan, Distinguished Professor, Xiamen University; Co-Founder of NanoFCM Inc.
Location
ADDRESS
Shenzhen Naive S Hotel(Xili Metro Station)
No. 1378 Liuxian Avenue
Xili Street, Nanshan District
Shenzhen City, Guangdong Province
China